{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"MoonLake Immunotherapeutics"},"Symbol":{"label":"Symbol","value":"MLTX"},"Address":{"label":"Address","value":"DORFSTRASSE 29, ZUG, 6300, Switzerland"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.moonlaketx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Dragos Budinschi","title":"Medical Director"},{"name":"Joao Neves","title":"Director-Information Technology"},{"name":"Jorge Santos da Silva","title":"Chief Executive Officer & Director"},{"name":"Kristian Reich","title":"Chief Scientific Officer"},{"name":"Nuala Brennan","title":"Chief Clinical Development Officer"},{"name":"Oliver Daltrop","title":"Chief Technical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}